Type I autoimmunity in chronic spontaneous urticaria: Evidence, limits, and endotype overlap.

Authors

George N Konstantinou, Clive E H Grattan

Published in

The Journal of allergy and clinical immunology. Oct 13, 2026. Epub Oct 13, 2026.

Abstract

Chronic spontaneous urticaria (CSU) is a mast cell-driven disorder with basophil involvement and several possible upstream mechanisms. Type IIb autoimmune CSU, mediated by functional IgG autoantibodies against FcεRIα or IgE, is the best-validated endotype. Evidence for type I autoimmune (autoallergic) CSU is less complete, but findings involving IgE autoantibodies to thyroid peroxidase (TPO), IL-24, and other self-antigens suggest that IgE-dependent autoreactivity may be relevant in some patients. However, total IgE level, atopy, allergic disease, and timing of the response to omalizumab are not diagnostic of this mechanism. Rather than viewing type I and type IIb CSU as competing categories, we hypothesize 2 potentially overlapping immunologic axes: an IgE-autoantibody axis and an IgG/complement axis. Patients may lie closer to one axis, show markers of both, or remain provisionally idiopathic because current biomarkers cannot classify them with confidence. Progress will require harmonized functional assays; skin, mast cell, and basophil readouts, as well as longitudinal treatment studies. The central question is when an IgE autoantibody is only a passenger, when it is a partner, and when it is the driver of the wheal.

PMID:
42869400
Bibliographic data and abstract were imported from PubMed on 14 Oct 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.